261 related articles for article (PubMed ID: 11642086)
1. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
Mazurov AV; Pevzner DV; Khaspekova SG; Dudnik OA; Byzova TV; Vlasik TN; Bakharev VN; Pistsov MIu; Staroverov II; Ruda MIa
Ter Arkh; 2001; 73(9):66-73. PubMed ID: 11642086
[TBL] [Abstract][Full Text] [Related]
2. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.
Mazurov AV; Pevzner DV; Antonova OA; Byzova TV; Khaspekova SG; Semenov AV; Vlasik TN; Samko AN; Staroverov II; Ruda MY
Platelets; 2002 Dec; 13(8):465-77. PubMed ID: 12487780
[TBL] [Abstract][Full Text] [Related]
3. Natural antibodies against the immunoglobulin F(ab')2 fragment cause elimination of antigens recognized by the F(ab')2 from the circulation.
Yano S; Kaku S; Suzuki K; Terazaki C; Sakayori T; Kawasaki T; Kawamura K; Sugita Y; Hoshino K; Masuho Y
Eur J Immunol; 1995 Nov; 25(11):3128-33. PubMed ID: 7489753
[TBL] [Abstract][Full Text] [Related]
4. [Identification of human platelet specific functional antibody and its fragments].
Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
[TBL] [Abstract][Full Text] [Related]
5. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacodynamics, safety, and clinical effects of a novel glycoprotein IIb/IIIa antagonist framon during high risk coronary angioplasty].
Mazurov AV; Pevzner DV; Semenov AV; Antonova OA; Dudnik OA; Khaspekova SG; Vlasik TN; Samko AN; Staroverov II; Ruda MIa
Kardiologiia; 2002; 42(6):8-17. PubMed ID: 12494124
[TBL] [Abstract][Full Text] [Related]
7. [Antiplatelet effects of glycoproteins IIb-IIIa antagonist monafram].
Mazurov AV; Pevzner DV; Vlasik TN; Ruda MIa
Ross Fiziol Zh Im I M Sechenova; 2004 May; 90(5):586-99. PubMed ID: 15341084
[TBL] [Abstract][Full Text] [Related]
8. A novel mechanism for exposure of fibrinogen binding sites on GPIIb-IIIa by a monoclonal antibody.
Hato T; Watanabe A; Nakatani S; Minamoto Y; Fujita S
Thromb Haemost; 1995 Jan; 73(1):138-43. PubMed ID: 7537917
[TBL] [Abstract][Full Text] [Related]
9. Effects of IgG and its F(ab')2 fragments of some patients with idiopathic thrombocytopenic purpura on platelet aggregation.
Chu XX; Hou M; Peng J; Zhu YY; Ji XB; Wang L; Zhang F; Ma DX
Eur J Haematol; 2006 Feb; 76(2):153-9. PubMed ID: 16405437
[TBL] [Abstract][Full Text] [Related]
10. 7E3 F(ab')2, an effective antagonist of rat alphaIIbbeta3 and alphavbeta3, blocks in vivo thrombus formation and in vitro angiogenesis.
Sassoli PM; Emmell EL; Tam SH; Trikha M; Zhou Z; Jordan RE; Nakada MT
Thromb Haemost; 2001 May; 85(5):896-902. PubMed ID: 11372685
[TBL] [Abstract][Full Text] [Related]
11. Exposure of platelet fibrinogen receptors by a monoclonal antibody to the GPIIb-IIIa complex, PMA4.
Watanabe A; Hato T; Kobayashi Y
Int J Hematol; 1992 Aug; 56(1):79-87. PubMed ID: 1382664
[TBL] [Abstract][Full Text] [Related]
12. Role of glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) in stimulation of secretion from platelet granules.
Naimushin YA; Mazurov AV
Biochemistry (Mosc); 2003 Feb; 68(2):209-16. PubMed ID: 12693968
[TBL] [Abstract][Full Text] [Related]
13. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of Fc-receptor dependent platelet aggregation by monoclonal antibodies against the glycoprotein IIb-IIIa complex].
Vinogradov DV; Vlasik TN; Agafonova OG; Vasil'ev SA; Lagutina NIa; Makarov VA; Berndt M; Mazurov AV
Biokhimiia; 1991 May; 56(5):787-97. PubMed ID: 1747408
[TBL] [Abstract][Full Text] [Related]
15. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
[TBL] [Abstract][Full Text] [Related]
17. Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation.
Clezardin P; Malaval L; Morel MC; Guichard J; Lecompte T; Trzeciak MC; Dechavanne M; Breton-Gorius J; Delmas PD; Kaplan C
J Bone Miner Res; 1991 Oct; 6(10):1059-70. PubMed ID: 1796754
[TBL] [Abstract][Full Text] [Related]
18. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. I. Adjunctive therapy with monoclonal antibody 7E3 F(ab')2 fragment.
Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR
J Cardiovasc Pharmacol; 1994 Feb; 23(2):194-202. PubMed ID: 7511747
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
Gold HK; Gimple LW; Yasuda T; Leinbach RC; Werner W; Holt R; Jordan R; Berger H; Collen D; Coller BS
J Clin Invest; 1990 Aug; 86(2):651-9. PubMed ID: 2384607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
